TransIT®-Jurkat Transfection Reagent is specifically optimized to provide exceptional transfection efficiency of plasmid DNA in Jurkat cells and cell types of associated lineage. Jurkat cells (human T-lymphocyte; acute T-cell leukemia cell line) have been inherently difficult to transfect, yet have remained a prevalent cell line in the immunological research field. TransIT-Jurkat reagent also works well for additional cell lines of hematopoietic origin such as THP-1(human acute monocytic leukemia cell line) and RAW264.7 (mouse monocyte/macrophage cell line). TransIT-Jurkat reagent provides many attributes of the trusted TransIT series of transfection reagents: high efficiency, serum compatibility, simplicity of use, and reproducibility. Transfection performed using the TransIT-Jurkat Reagent does not require medium changes and can be carried out in serum-containing medium. TransIT-Jurkat is suitable for both transient and stable transfection.
↓ Mirus Transit-Jurkat Full Transfection Protocol
MIR 2120 | TransIT®-Jurkat Transfection Reagent | 1 ml |
MIR 2125 | TransIT®-Jurkat Transfection Reagent | 5 X 1 ml |
MIR 2126 | TransIT®-Jurkat Transfection Reagent | 10 X 1 ml |